Primary duodenal follicular lymphoma successfully treated with rituximab

Clinical and Translational Oncology

Volumn 9, Issue 7, 2007, Pages 471-472

  Aguiar Bujanda, D ^a   Quinones Morales I ^a   Camacho Galan R ^a   Llorca Martinez I ^a   Rivero Vera, J C ^a   Bohn Sarmiento, U ^a   Aguiar Morales, J ^a  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

Duodenal follicular lymphoma; Gastrointestinal tract lymphoma; Immunotherapy; Non Hodgkin's lymphoma; Rituximab

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD20 ANTIGEN; CD79 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN BCL 2; PROTEIN BCL 6; RITUXIMAB; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ABSENCE OF SIDE EFFECTS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; COOMBS TEST; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; DRUG EFFICACY; DUODENUM BIOPSY; DUODENUM CANCER; ECHOGRAPHY; FOLLICULAR LYMPHOMA; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LIVER CIRRHOSIS; MALE; NONALCOHOLIC FATTY LIVER; PORTAL HYPERTENSION; PRIMARY DUODENAL FOLLICULAR LYMPHOMA; PROTHROMBIN TIME; THROMBOCYTOPENIA; DUODENUM TUMOR; MIDDLE AGED;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; DUODENAL NEOPLASMS; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED;

EID: 35748932063     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0088-2     Document Type: Article

References (16)

1. Koch P, del Valle F, Berdel WE et al (2001) Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German multicenter study GIT NHL 01/92. J Clin Oncol 19:3861-3873
2. Gurney KA, Cartwright RA, Gilman EA (1999) Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry. Br J Cancer 79:1929-1934
3. Amer MH, El-Akkad S (1994) Gastrointestinal lymphoma in adults: Clinical features and management of 300 cases. Gastroenterology 106:846-858
4. Damaj G, Verkarre V, Delmer A et al (2003) Primary follicular lymphoma of the gastrointestinal tract: A study of 25 cases and a literature review. Ann Oncol 14:623-629
5. Yoshino T, Miyake K, Ichimura K et al (2000) Increased incidence of follicular lymphoma in the duodenum. Am J Surg Pathol 24:688-693
6. Shia J, Teruya Feldstein J, Pan D et al (2002) Primary follicular lymphoma of the gastrointestinal tract: A clinical and pathologic study of 26 cases. Am J Surg Pathol 26:216-224
7. Harris NL, Jaffe ES, Diebold J et al (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. J Clin Oncol 17:3835-3849
8. Bende RJ, Smit LA, Bossenbroek JG et al (2003) Primary follicular lymphoma of the small intestine: Alpha4beta7 expression and immunoglobulin configuration suggest an origin from local antigen-experienced B cells. Am J Pathol 162:105-113
9. Misdraji J, Del Castillo CF, Ferry JA (1997) Follicle center lymphoma of the ampulla of Vater presenting with jaundice: Report of a case. Am J Surg Pathol 21:484-488
10. Ahmed S, Singh A, Krauss J et al (2003) Successful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-cd20 monoclonal antibody. Am J Clin Oncol 26:408-410
11. Zenda T, Masunaga T, Fuwa B et al (2005) Small follicular lymphoma arising near the ampulla of Vater. A distinct subtype of duodenal lymphoma? J Gastrointest Cancer 36:113-120
12. Takamura M, Narisawa R, Maruyama Y et al (2006) A primary follicular lymphoma of the duo denum treated successfully with radiation therapy. Intern Med 45:309-311
13. Grillo-Lopez AJ, White CA, Varns C et al (1999) Overview of the clinical development of rituximab: First monoclonal antibody approved for the treatment of lymphoma. Semin Oncol 26[5 Suppl 14]:66-73
14. Hiddemann W, Kneba M, Dreyling M et al (2005) Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: Results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 106:3725-3732
15. Coiffier B, Lepage E, Briere J et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235-242
16. Al-Salman J, Salib H, Boonswang P (2001) Successful treatment of gastrointestinal follicular lymphoma with rituxan and combination chemotherapy. Med Oncol 18:277-283